Jonathan Miller
Stock Analyst at Evercore ISI Group
(0.96)
# 2,726
Out of 4,479 analysts
5
Total ratings
20%
Success rate
4.89%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROK ProKidney | Initiates: Outperform | n/a | $2.24 | - | 1 | Sep 2, 2022 | |
| VAXX Vaxxinity | Initiates: In-Line | n/a | $0.27 | - | 1 | Apr 27, 2022 | |
| TRDA Entrada Therapeutics | Initiates: Outperform | n/a | $14.00 | - | 1 | Nov 24, 2021 | |
| STTK Shattuck Labs | Initiates: Outperform | n/a | $3.64 | - | 1 | Jan 11, 2021 | |
| NBTX Nanobiotix | Initiates: Outperform | n/a | $5.24 | - | 1 | Jan 6, 2021 |
ProKidney
Sep 2, 2022
Initiates: Outperform
Price Target: n/a
Current: $2.24
Upside: -
Vaxxinity
Apr 27, 2022
Initiates: In-Line
Price Target: n/a
Current: $0.27
Upside: -
Entrada Therapeutics
Nov 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $14.00
Upside: -
Shattuck Labs
Jan 11, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.64
Upside: -
Nanobiotix
Jan 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.24
Upside: -